Detalhe da pesquisa
1.
Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting.
Biol Blood Marrow Transplant
; 24(11): 2354-2359, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859255
2.
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.
Leuk Lymphoma
; 61(12): 2931-2938, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842815